A Blood Test for Alzheimer’s Disease: Progress, Challenges, and Recommendations

SJK was supported by an MRC Career Development Award in Biostatistics (MR/L011859/1). Nicola Voyle is funded by the Alzheimer’s Society. The authors acknowledge infrastructure support from the National Institute for Health Research (NIHR) Biomedical Research Centre for Mental Health. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement no 115372, resources of which are composed of financial contribution from the European Union’s Seventh Framework Programme (FP7-/2007-2013) and in-kind contribution from EFPIA companies. This work was supported by awards to establish the Farr Institute of Health Informatics Research, London, from the Medical Research Council, Arthritis Research UK, British Heart Foundation, Cancer Research UK, Chief Scientist Office, Economic and Social Research Council, Engineering and Physical Sciences Research Council, National Institute for Health Research, National Institute for Social Care and Health Research, and Wellcome Trust (grant MR/K006584/1).